Youjia Jiankang Closes ￥10M Series A+ Round

According to VCBeat, on July 27, Youjia Jiankang announced the closure of a Series A+ round of tens of millions. Investors include Dongfang Hongtai Capital and Pins Medical. The funds raised will be used to further consolidate the industry-leading collaborative medical network covering the whole country, develop a data-driven medical and health product innovation platform, and improve health insurance risk management.

Within two years after its establishment, Youjia Jiankang has respectively received investments from Legend Star in an angel round and Joy Capital in Series A financing.

Established in July 2017, along with the high-speed development of commercial health insurance, Youjia Jiankang connects healthcare services, insurance, and users, providing commercial health insurance companies and its users with direct payments and risk management. Based on the S2B2C business pattern, with the construction of medical networks and systems, the number of team members and customers continues to increase.

So far, Youjia Jiankang has gradually set up 6 kinds of medical networks nationwide to provide commercial insurance companies (to B) with risk control management and product innovation platform. Youjia Jiankang has also developed health management services in full life cycle to clients (to C). It has clients including nearly hundreds of large and medium-sized insurance companies and Internet platforms, and serve millions of customers.

Based on the S2B2C pattern and the cloud platform combining its online data with offline network services, Youjia Jiankang helps insurance companies in product design, medical network, health services and risk control, etc. It provides patients with professional services such as intelligent guidance of examining, chronic disease management, examination arrangement, direct payment of hospitalization, and after-hospital care.

Since its establishment in September 2014, Dongfang Hongtai Capital has launched five RMB funds with a total amount of about 9 billion yuan. So far, it has become a leading investment firm in China with overseas reputation.

Founded in 2008, Pins Medical has grown to become a leading manufacturer of products for the neuroregulatory system in China. The company's main products include brain pacemakers, vagus nerve stimulation devices and sacral nerve stimulation devices.